Key diabetes drug to cost up to 90% less in a few days | India News
NEW DELHI: Several domestic drug companies are set to transform diabetes therapy by launching the blockbuster drug Empagliflozin at a...
Rupali Mukherjee
NEW DELHI: Several domestic drug companies are set to transform diabetes therapy by launching the blockbuster drug Empagliflozin at a...
